IBA (Ion Beam Applications S.A.), a provider of proton therapy solutions for treating cancer, has unveiled its unique platform, Leading the PATh, which gathers the leading experts in proton therapy in one place. It is anticipated that Leading the PATh will enable the worldwide medical community to shape the most efficient Proton Adaptive Therapy (PATh), a proton therapy process that improves accuracy.
The platform www.leadingthepath.org will enable physicians, physicists, academics, researchers, industry experts, patient association advocates and policymakers to exchange experiences, discuss best practices and enhance knowledge, to improve the next generation of proton therapy treatment.
This platform also includes access to a research software platform. This software will be distributed under an open-source license to foster creativity and innovation within the proton therapy community. In addition, users will be invited to access and test a software application that proposes a new example of proton adaptive workflow.
“Open-mindedness and willingness to foster collaboration across the medical community has always been part of IBA’s DNA,” says Damien Bertrand, Strategic Partnerships Coordinator. “Sharing expertise and best practice will help the community win the fight against cancer. We are very proud to be part of this one-of-a-kind mobilization, and we remain determined to help our clinical partners alleviate the burden of the patients who are the center of our attention at all times.”Back To Top
ASTRO 2016: IBA to open the "PATh" toward adaptive proton therapy. Appl Rad Oncol.